Idelalisib - A PI3Kδ inhibitor for B-cell cancers Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Class Ia Phosphatidylinositol 3-Kinase
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Non-Hodgkin
  • Purines
  • Quinazolinones

publication date

  • March 17, 2014

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1056/NEJMe1400055

Additional Document Info

start page

  • 1061

end page

  • 2

volume

  • 370

number

  • 11